Mapap
NDC 21695-267
Product Information
Mapap is a OTC MONOGRAPH NOT FINAL-approved product labeled by Rebel Distributors Corp. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a red product. This product entry covers the primary NDC 21695-267 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 21695-267?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- BUTYLPARABEN (UNII: 3QPI1U3FV8)
- CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)
- CARRAGEENAN (UNII: 5C69YCD2YJ)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- GLYCERIN (UNII: PDC6A3C0OX)
- HIGH FRUCTOSE CORN SYRUP (UNII: XY6UN3QB6S)
- HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%) (UNII: R33S7TK2EP)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- WATER (UNII: 059QF0KO0R)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SORBITOL (UNII: 506T60A25R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1048963 - acetaminophen 100 MG/ML Oral Suspension [Mapap]
- RxCUI: 1048963 - APAP 100 MG/ML Oral Suspension [Mapap]
- RxCUI: 1048963 - Mapap 100 MG/ML Oral Suspension
- RxCUI: 1048963 - Mapap 80 MG per 0.8 ML Oral Suspension
- RxCUI: 1048963 - Mapap Infants' Concentrated Drops 10 % Oral Suspension
* Please review the full disclaimer at the bottom of this page.